Welcome to our dedicated page for Ambase SEC filings (Ticker: ABCP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The AmBase Corporation (ABCP) SEC filings page provides access to the company’s regulatory disclosures, including annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K. These documents, filed under the Securities Exchange Act of 1934, contain detailed information on AmBase’s financial condition, results of operations, risk factors, and legal proceedings.
AmBase’s filings state that its financial statements include a qualification about the company’s ability to continue as a going concern. The periodic reports discuss this qualification in the context of the company’s need for additional funding to support operations and litigation related to its interest in the 111 West 57th Property. Users can review the 10-K and 10-Q filings to see management’s discussion of these issues, as well as disclosures under headings such as “Risk Factors” and “Cautionary Statement for Forward-Looking Information.”
Current reports on Form 8-K for ABCP frequently disclose material definitive agreements, including senior promissory notes with company management and other funding arrangements. These 8-Ks describe key terms such as loan amounts, interest rates, maturity provisions tied to future funding events or specified dates, and options to convert obligations into litigation funding agreements on terms pari passu with third-party litigation funding. Exhibits to these filings, such as promissory notes and related agreements, are incorporated by reference.
Through this page, users can also monitor any equity or financing transactions that require SEC disclosure, as well as updates on legal proceedings involving the 111 West 57th Property. AI-powered summaries on the platform can help explain the structure and implications of complex filings, including how AmBase’s funding arrangements relate to its litigation strategy and going concern qualification.
AmBase Corporation reported that its Chairman, President and CEO, Richard A. Bianco, has provided the company with a $300,000 senior promissory note to supply working capital. The loan carries a 6.5% annual interest rate and is due on the earlier of the company receiving sufficient funds from any source to repay all principal and interest, potentially excluding certain litigation funding for the 111 West 57th legal proceedings, or December 31, 2028.
Mr. Bianco may convert amounts owed under the note into a litigation funding agreement on the same terms as any such agreement the company enters with a litigation funder. AmBase reiterates that its financial statements include a going concern qualification and that it is actively evaluating additional funding options, including litigation funding agreements, equity or debt securities, and loans. It is exploring up to $5 million of additional litigation funding, where funders typically recover their capital first plus a multiple of 1.0x to 3.5x and possible extra fees or a share of any recovery.
AmBase Corporation entered into a Senior Promissory Note under which its Chairman, President and CEO, Richard A. Bianco, is lending the company
Mr. Bianco may also convert amounts owed under the note into a litigation funding agreement on a pari-passu basis with any third-party litigation funders. AmBase reiterates that its financial statements include a going concern qualification and that it is actively evaluating additional funding options, including litigation funding agreements for up to
AmBase Corporation filed its quarterly report for the period ended September 30, 2025, reporting a net loss of $1.091 million for Q3 and $3.766 million for the nine months. Management states there is substantial doubt about the company’s ability to continue as a going concern based on current cash resources and expected needs.
Cash and cash equivalents were $239,000 at September 30, 2025, against total liabilities of $8.130 million, driven primarily by related‑party loans of $2.0 million (BARC Investments LLC) and $3.2 million (R.A. Bianco). Stockholders’ equity was a deficit of $7.891 million. Q3 operating expenses were $985,000, down from $1.523 million a year ago; interest expense for the nine months was $245,000.
The company continues multiple legal actions related to its former investment in the 111 West 57th Property. The court set a bench trial for November 30, 2026 in two matters, with interim decisions issued on September 9, 2025 and appeal activity continuing. During 2025, AmBase recorded $124,000 of other income from an employee retention credit refund.
AmBase Corporation reported the execution of a Senior Promissory Note in the principal amount of
FAQ
What is the current stock price of Ambase (ABCP)?
What is the market cap of Ambase (ABCP)?
